Table 3.
Outcomes in baseline, perioperative period, and extended follow-up (n = 37)
| Baseline | Perioperative period* | Extended follow-up† | |||
|---|---|---|---|---|---|
| Echocardiography parameters | Median (CI 95%) | Median (CI 95%) | Median (CI 95%) | p-value§ | p-value‡ |
| AV peak gradient (mmHg) | 70 (50.03-79.86) | 14 (11.93-17.5) | 12 (10.9-17.7) | < 0.0001 | < 0.0001 |
| AV mean gradient (mmHg) | 45.5 (30.6-49.68) | 07 (5.93-9.6) | 06 (5.2-9.2) | < 0.0001 | < 0.0001 |
| LVEF (%) | 58.5 (52.1-60.9) | 60 (53.32-60.61) | 60 (55.81-61.79) | 0.8127 | 0.1928 |
| Aortic regurgitation, n (%) | p-value¶ | p-value** | |||
| 0-I | 13 (35.1) | 35 (94.6) | 33 (89.1) | < 0.01†† | < 0.01†† |
| II-III | 13 (35.1) | 01 (2.7) | 03 (9.1) | ||
| IV | 12 (32.4) | 00 (00) | 00 (00) | ||
| Clinical variables, n (%) | |||||
| All-cause mortality | - | 01 (2.7) | 01 (2.7) | NA | NA |
| Stroke | - | 00 (00) | 00 (00) | NA | NA |
| Myocardial infarction | - | 02 (5.4) | 02 (5.4) | NA | NA |
| ACO use | 08 (21.6) | 08 (21.6) | 10 (27.0) | NA | NA |
| Definitive pacemaker | - | 01 (2.7) | 02 (5.4) | NA | NA |
| Redo-surgery for valve dysfunction | - | 00 (00) | 00 (00) | NA | NA |
| Functional class (NYHA), n (%) | |||||
| I | 01 (2.7) | 15 (40.5) | 32 (86.5) | ||
| II-III | 36 (97.3) | 21 (56.8) | 04 (10.8) |
*
First 30 postoperative days;
†
19 months on average; NA: Not Applicable.
‡
Wilcoxon signed-rank test for dependent measures (perioperative period vs. baseline).
§
Wilcoxon signed-rank test for dependent measures (extended follow-up vs. baseline).
¶
Exact McNemar test for dependent categorical measures (perioperative period up vs. baseline).
**
Exact McNemar test for dependent categorical measures (extended follow-up vs. baseline).
††
Hypothesis test performed for binary collapsed data (II-IV vs. 0-I).